A brain health framework with application to the study of neurodegeneration
Open Access
- 4 August 2025
- journal article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 107 (3) , 960-972
Abstract
An all-encompassing framework seems necessary for understanding brain health in the context of neurodegeneration, particularly due to Alzheimer's disease (AD). We argue that current views, dominated by the amyloid-beta hypothesis, oversimplify the complexity of brain degeneration. We propose a multi-scale, multi-entity approach, treating the brain as a complex system composed of interacting subsystems across various scales, from the nanoscale (genes and proteins) to the macroscale (cognition) and beyond. By redefining brain health through mathematical complexity, we emphasize the importance of integrating diverse biological, environmental, and lifestyle factors to account for the heterogeneity in AD presentations. This framework suggests that failures at different levels of brain function can lead to cascading effects that influence neurodegenerative trajectories. Additionally, it calls for a shift toward personalized treatment approaches that target multiple yet specific pathological mechanisms affecting an individual. We propose computational models as essential tools for simulating and testing these complex interactions. Through this framework, we aim to provide a deeper understanding of neurodegeneration, and advocate for more comprehensive and multi-factorial approaches in both research and clinical practice to advance the treatment of brain health disorders such as AD.Keywords
This publication has 73 references indexed in Scilit:
- Alzheimer Disease as a Clinical-Biological Construct—An International Working Group RecommendationJAMA Neurology, 2024
- Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s DiseaseBioDrugs, 2023
- Donanemab in Early Symptomatic Alzheimer DiseaseJAMA, 2023
- Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019Alzheimer's & Dementia, 2020
- 2020 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2020
- The puzzle of preserved cognition in the oldest oldNeurological Sciences, 2019
- Genetic risk for alzheimer disease is distinct from genetic risk for amyloid depositionAnnals of Neurology, 2019
- Person‐specific contribution of neuropathologies to cognitive loss in old ageAnnals of Neurology, 2017
- Network News: Innovations in 21st Century Systems BiologyCell, 2011
- Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaquesAnnals of Neurology, 1988